A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout.
Latest Information Update: 19 Aug 2024
At a glance
- Drugs Etoricoxib (Primary) ; Indometacin
- Indications Gout; Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Merck Sharp & Dohme Corp.
Most Recent Events
- 23 Jan 2010 New trial record